John L Villano

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Mycobacterium Tuberculosis

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

Journal of neuro-oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Louis T Rodgers, John L Villano, Anika M S Hartz, Bjoern Bauer
Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models. Cancers 16 (15) (2024)
Megan Leigh Hutchcraft, Shulin Zhang, Nan Lin, Justine C Pickarski, Elizabeth A Belcher, Sainan Wei, Therese Bocklage, Rachel W Miller, John L Villano, Michael J Cavnar, Joseph Kim, Susanne M Arnold, Frederick Rand Ueland, Jill M Kolesar
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. JCO precision oncology 8 (2024)
Megan Leigh Hutchcraft, Shulin Zhang, Nan Lin, Justine C Pickarski, Elizabeth A Belcher, Sainan Wei, Therese Bocklage, Rachel W Miller, John L Villano, Michael J Cavnar, Joseph Kim, Susanne M Arnold, Frederick Rand Ueland, Jill M Kolesar
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. JCO precision oncology 8 (2024)
Megan Leigh Hutchcraft, Shulin Zhang, Nan Lin, Justine C Pickarski, Elizabeth A Belcher, Sainan Wei, Therese Bocklage, Rachel W Miller, John L Villano, Michael J Cavnar, Joseph Kim, Susanne M Arnold, Frederick Rand Ueland, Jill M Kolesar
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. JCO precision oncology 8 (2024)
Megan Leigh Hutchcraft, Shulin Zhang, Nan Lin, Justine C Pickarski, Elizabeth A Belcher, Sainan Wei, Therese Bocklage, Rachel W Miller, John L Villano, Michael J Cavnar, Joseph Kim, Susanne M Arnold, Frederick Rand Ueland, Jill M Kolesar
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. JCO precision oncology 8 (2024)
Alexandra N Demetriou, Frances Chow, David W Craig, Michelle G Webb, D Ryan Ormond, James Battiste, Arnab Chakravarti, Howard Colman, John L Villano, Bryan P Schneider, James K C Liu, Michelle L Churchman, Gabriel Zada
Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database. Neuro-oncology advances 6 (1) (2024)
Louis T Rodgers, John L Villano, Anika M S Hartz, Bjoern Bauer
Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models. Cancers 16 (15) (2024)
Louis T Rodgers, John L Villano, Anika M S Hartz, Bjoern Bauer
Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models. Cancers 16 (15) (2024)
Alexandra N Demetriou, Frances Chow, David W Craig, Michelle G Webb, D Ryan Ormond, James Battiste, Arnab Chakravarti, Howard Colman, John L Villano, Bryan P Schneider, James K C Liu, Michelle L Churchman, Gabriel Zada
Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database. Neuro-oncology advances 6 (1) (2024)
Olivier Rixe, John L Villano, Robert Wesolowski, Anne M Noonan, Vinay K Puduvalli, Trisha Michel Wise-Draper, Richard Curry, Emrullah Yilmaz, Charlie Cruze, Besim Ogretmen, Gilles Tapolsky, Ray Takigiku
A first-in-human phase 1 study of BXQ-350, a first-in-class sphingolipid metabolism regulator, in patients with advanced/recurrent solid tumors or high-grade gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, Jeffrey J Raizer, Martha M Matuszak, Enrico C Lallana, Jiayi Huang, Ozer Algan, Nimisha Deb, Lorraine Portelance, John L Villano, John T Hamm, Kevin S Oh, Arif N Ali, Michelle M Kim, Scott M Lindhorst, Minesh P Mehta
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rachel W Miller, Megan Leigh Hutchcraft, Heidi L Weiss, Jianrong Wu, Chi Wang, Jinpeng Liu, Rani Jayswal, Mikayla Buchanan, Abigail Anderson, Derek B Allison, Riham H El Khouli, Reema A Patel, John L Villano, Susanne M Arnold, Jill M Kolesar
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial. JCO precision oncology 6 (2022)
Bin Huang, Quan Chen, Derek Allison, Riham H El Khouli, Keng Hee Peh, James Mobley, Abigail Anderson, Eric B Durbin, Donald Goodin, John L Villano, Rachel W Miller, Susanne M Arnold, Jill M Kolesar
Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung Cancer. JCO precision oncology 5 (2021)
Catherine R Garcia, Zin W Myint, Rani Jayswal, Chi Wang, Rachael M Morgan, Allison R Butts, Heidi L Weiss, John L Villano
Hematological adverse events in the management of glioblastoma. Journal of neuro-oncology (2021)
Eudocia Quant Lee, Peixin Zhang, Patrick Y Wen, Elizabeth R Gerstner, David A Reardon, Kenneth D Aldape, John F deGroot, Edward Pan, Jeffrey J Raizer, Lyndon J Kim, Steven J Chmura, H Ian Robins, Jennifer M Connelly, James D Battiste, John L Villano, Naveed Wagle, Ryan T Merrell, Merideth M Wendland, Minesh P Mehta
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. Cancer 126 (12) (2020)
Catherine R Garcia, Stacey A Slone, Therese A Dolecek, Bin Huang, Janna H Neltner, John L Villano
Primary central nervous system tumor treatment and survival in the United States, 2004-2015. Journal of neuro-oncology 144 (1) (2019)
Catherine R Garcia, Rani Jayswal, Val Adams, Lowell B Anthony, John L Villano
Multiple sclerosis outcomes after cancer immunotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (10) (2019)
Emily V Dressler, Meng Liu, Catherine R Garcia, Therese A Dolecek, Thomas Pittman, Bin Huang, John L Villano
Patterns and disparities of care in glioblastoma. Neuro-oncology practice 6 (1) (2018)
Thomas Huang, Brigitte J Engelmann, Rachael M Morgan, Kimberly J Absher, Jill M Kolesar, John L Villano
EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib. Cancer chemotherapy and pharmacology 81 (5) (2018)
Catherine R Garcia, Stacey A Slone, Thomas Pittman, William H St Clair, Donita D Lightner, John L Villano
Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas. PloS one 13 (9) (2018)
Meng Liu, Jigisha P Thakkar, Catherine R Garcia, Therese A Dolecek, Lars M Wagner, Emily Van Meter Dressler, John L Villano
National cancer database analysis of outcomes in pediatric glioblastoma. Cancer medicine 7 (4) (2018)
Zhengqiu Zhou, Tracy A Howard, John L Villano
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma. Cancer chemotherapy and pharmacology 80 (5) (2017)